API Manufacturers Index A to Z

Browse Alphabetically

MANUFACTURING - World Class Standards & Exceptional QualityOur excellence in quality is reflected in the production facilities, monitoring and control systems and the comprehensive training of our staff. Our laboratory and management system are ISO certified, and a world-class GMP is upheld throughout the manufacturing process.DOSSIER - More Than 40 Years of Professional Pharmaceutical ExpertiseWe...Read More

Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing clinically effective anti-infective treatments against serious and often life-threatening infections. With over 100 years of pharmaceutical industry expertise, we are a leading developer, manufacturer and trusted supplier of fermented and semi-synthetic Active Pharmaceutical Ingredients (APIs) and finished dosage forms...Read More

We are a fast growing Indian Pharmaceutical & Nutraceutical manufacturing company, working relentlessly towards our goal of providing world class quality medicines at affordable prices.We manufacture a wide range of prescription drugs and over the counter medications. In addition, our offerings also include dietary supplements and phyto-pharmaceuticals.With a large portfolio of over 500 molecules in...Read More

Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & DMF available. The company's registered capital reaches CNY 75 million. The building area of company is over 2,000,000 square meters. All the workshops are compliant with GMP requirements. There are more than 700 employees...Read More

Xcelience delivers efficient, cost-effective and innovative scientific solutions to pharmaceutical and biotech companies around the world. Xcelience Suite Science sets us apart from the pack. We offer a full range of services from preformulation and development through manufacturing, small-scale commercial manufacturing and clinical packaging and logistics for our clients’ Phase I-III clinical outsourcing...Read More

Xcelris is India's leading genomics research organization offering cutting edge solutions to researchers across fields such as agriculture, human health, animal science, wildlife conservation, bio-energy, microbial and environmental genetics. Xcelris partners with the biotechnology industry, academia, research institutes and individual researchers in India and abroad. Xcelris caters to the needs of...Read More

Since its establishment in 1996 , the company advancing with the times, pioneering and innovative, advanced technology, well-equipped, all the hardware according to GMP, GSP standards for the design and complete introduction of foreign advanced detection systems, first-class product quality, in particular, the world invention patent products and Nine categories of new drug products have reached the...Read More

AMOYTOP BIOTECH, the leading manufacturer of recombinant bio-pharmaceutical products in China with cGMP, produce Molgramostim, Filgrastim, Oprelvekin, Interferon-alfa-2a, Interferon-alfa-2b, Interferon gamma, Interleukin-2, Somatropin, and provide bio-reagents, such as Interleukin-4, TNF, recombinant human SOD. AMOYTOP is also developing Y-shaped branch PEG Drug Delivery Technology in: YPeg-filgrastim,...Read More

X4 is focused on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Our first-in-class, oral, small molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. A number of PIs are attributed to the improper trafficking...Read More

Xenon is focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Our goal is to build a self-sustaining, fully-integrated, and profitable company that discovers, develops and commercializes innovative CNS therapeutics, including novel, selective ion channel modulators. We intend to expand our pipeline with therapeutic candidates from our internal...Read More

PharmaCompass >>